Trexquant Investment LP Collegium Pharmaceutical, Inc Transaction History

Trexquant Investment LP

$7.59 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$31.36 - $39.99 $2.9 Million - $3.7 Million	-92,421 Reduced 85.4%	15,806 $508,000
Q1 2024 May 14, 2024	BUY	$31.23 - $40.91 $426,289 - $558,421	13,650 Added 14.43%	108,227 $4.2 Million
Q4 2023 Feb 09, 2024	SELL	$21.16 - $30.8 $812,586 - $1.18 Million	-38,402 Reduced 28.88%	94,577 $2.91 Million
Q3 2023 Nov 13, 2023	BUY	$21.23 - $24.28 $693,796 - $793,470	32,680 Added 32.58%	132,979 $2.97 Million
Q2 2023 Aug 11, 2023	SELL	$21.06 - $24.0 $324,913 - $370,272	-15,428 Reduced 13.33%	100,299 $2.16 Million
Q1 2023 May 15, 2023	BUY	$23.0 - $29.88 $2.42 Million - $3.15 Million	105,323 Added 1012.33%	115,727 $2.78 Million
Q4 2022 Feb 13, 2023	BUY	$16.14 - $23.55 $167,920 - $245,014	10,404 New	10,404 $241,000
Q4 2021 Feb 14, 2022	SELL	$17.5 - $21.35 $324,607 - $396,021	-18,549 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$17.75 - $25.39 $329,244 - $470,959	18,549 New	18,549 $366,000
Q2 2021 Aug 12, 2021	SELL	$21.74 - $25.28 $438,582 - $509,998	-20,174 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$19.25 - $26.1 $388,349 - $526,541	20,174 New	20,174 $478,000
Q3 2019 Nov 08, 2019	SELL	$10.16 - $13.28 $114,970 - $150,276	-11,316 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$10.62 - $16.59 $198,264 - $309,718	-18,669 Reduced 62.26%	11,316 $149,000
Q1 2019 May 13, 2019	SELL	$13.58 - $18.72 $42,043 - $57,957	-3,096 Reduced 9.36%	29,985 $454,000
Q4 2018 Feb 13, 2019	SELL	$14.78 - $19.68 $16,420 - $21,864	-1,111 Reduced 3.25%	33,081 $568,000
Q3 2018 Nov 09, 2018	BUY	$14.16 - $24.3 $484,158 - $830,865	34,192 New	34,192 $504,000
Q2 2018 Aug 07, 2018	SELL	$21.79 - $28.29 $512,805 - $665,776	-23,534 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$18.15 - $29.21 $427,142 - $687,428	23,534 New	23,534 $601,000

Others Institutions Holding COLL

# of Institutions

254

Shares Held

36.9M

Call Options Held

100K

Put Options Held

21.1K

Black Rock Inc. New York, NY

5.79M
Shares

$191 Million
0.0% of portfolio
Eventide Asset Management, LLC Boston, MA

2.64M
Shares

$86.7 Million
1.79% of portfolio
Pacer Advisors, Inc. Malvern, PA

2.59M
Shares

$85.2 Million
0.24% of portfolio
Vanguard Group Inc Valley Forge, PA

2.35M
Shares

$77.2 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.66M
Shares

$54.5 Million
0.1% of portfolio

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.12B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account